Five stocks stand out heading into Friday, August 28, 2026, each carrying a bullish rating change issued on Thursday, August 27. The market is digesting Nvidia's fiscal Q2 report from August 26 and Federal Reserve Chair Jerome Powell's Jackson Hole remarks. The Federal Open Market Committee held the federal funds target range at 3.50% to 3.75% at its July 29 meeting, and the CME Group FedWatch tool still prices roughly an 80% probability that policy rates hold steady through the balance of 2026.
The five ideas below span chip-design software, renewable energy, life sciences tools, self-storage real estate, and specialty chemicals. Each name received a specific thesis on Thursday. These are editorial notes for consideration only, not personalized investment advice.
Synopsys (SNPS) – Baird Turns Bullish After Post-Earnings Reset
Chip-design software leader Synopsys headlined Thursday's upgrades when Baird analyst Joe Vruwink moved the stock from Neutral to Outperform with a $560 price target. Vruwink argued that the post-earnings reset creates a favorable entry point, with Synopsys' EDA franchise remaining central to accelerating custom-silicon design activity across hyperscalers and AI chip startups. The Ansys integration also gives Synopsys a broader multiphysics simulation platform that widens the addressable market.
Shares traded near $460.77 during Thursday's session, up about 12.38% on the day, as the upgrade catalyzed a sharp rebound. The 52-week range of $366.00 to $615.79 shows the stock has room to reclaim its highs. The trailing price-to-earnings multiple sits at 193.2, reflecting integration-related earnings impact.
Consensus is constructive. Fifteen analysts rate Synopsys a buy, with 12 bullish, two neutral, and one bearish. The average price target of $563 implies roughly 22% upside from Thursday's level, and KeyBanc's Jason Celino holds the high at $650.
Risks: Not everyone is aligned. Mizuho's Siti Panigrahi maintained Outperform on August 27 but trimmed his target to $550 from $600, and Piper Sandler's Clarke Jeffries downgraded to Neutral in January. Ansys integration execution and pace of EDA license growth remain the key operational tests.
First Solar (FSLR) – BMO Sees a Bottom in Utility-Scale Solar
Utility-scale solar module maker First Solar was upgraded from Market Perform to Outperform on Thursday by BMO Capital analyst Ameet Thakkar, who raised his price target to $263 from $237. Thakkar's thesis: policy overhangs from the current administration's clean-energy stance are largely priced in, First Solar's domestic manufacturing footprint remains advantaged under Section 45X, and bookings visibility supports a re-acceleration in 2027 deliveries.
Shares traded near $209.23 during Thursday's session, up about 1.60%, giving First Solar a market capitalization near $22.5 billion. The 52-week range of $182.99 to $320.95 shows the stock has retraced significantly from its highs. The trailing price-to-earnings multiple stands at 12.9, one of the lower valuations among the day's upgraded names.
Consensus reads buy on 25 ratings, with 18 bullish, five neutral, and two bearish. The average price target of $262.92 implies roughly 26% upside from Thursday's level, and Deutsche Bank's Corinne Blanchard holds the high at $299.
Risks: Policy risk remains front and center. GLJ Research's Gordon Johnson downgraded to Hold in March with a $207.82 target, and any incremental changes to Inflation Reduction Act manufacturing credits or tariff enforcement could pressure the thesis. Utility-scale project financing conditions and interest-rate sensitivity also remain factors, along with competitive dynamics against domestic and foreign module makers.
Waters Corporation (WAT) – Piper Sandler Sees Instrument Cycle Turning
Life sciences instruments maker Waters was upgraded from Neutral to Overweight on Thursday by Piper Sandler analyst David Westenberg, who raised his price target to $480 from $400. Westenberg's thesis focuses on the emerging replacement cycle for liquid chromatography systems, improving pharma and biotech capital-expenditure trends, and BD Life Sciences integration synergies flowing through 2027 numbers.
Shares traded near $422.22 during Thursday's session, up about 1.94%, giving Waters a market capitalization near $31.6 billion. The 52-week range of $282.77 to $426.22 shows the stock trading near multi-year highs. The trailing price-to-earnings multiple sits at 105.3, elevated on integration-related earnings impacts.
Coverage tilts positive. Fifteen analysts rate Waters a buy, with nine bullish and six neutral. The average price target of $421.33 implies roughly flat return from Thursday's level, but TD Cowen's Dan Brennan upgraded to Buy on August 5 with a $475 target and Citigroup's Joanne Wuensch sits at $470.
Risks: The neutral camp is meaningful. Wells Fargo's Brandon Couillard maintained Equal-Weight in May with a $370 target, and UBS's Lu Li carries Neutral at $375. Pharma capex trends and BD Life Sciences integration execution remain the primary swing factors.
Extra Space Storage (EXR) – BMO Upgrades Self-Storage Leader
Self-storage REIT Extra Space Storage was upgraded from Market Perform to Outperform on Thursday by BMO Capital analyst Juan Sanabria, who raised his price target to $170 from $160. Sanabria pointed to stabilizing same-store revenue trends, disciplined new-supply growth in the sector, and the Life Storage integration continuing to generate cost synergies as reasons to turn constructive on the name.
Shares traded near $143.21 during Thursday's session, down about 0.61%, giving Extra Space a market capitalization near $30.3 billion. The 52-week range of $125.71 to $158.88 shows the stock caught in a consolidation range. The trailing price-to-earnings multiple is 32.0, and the dividend yield sits near 5%.
Consensus reads buy on 12 ratings, with five bullish and seven neutral. The average price target of $156.83 implies roughly 9% upside from Thursday's level, and BMO's fresh $170 marks the high alongside Wells Fargo's $170.
Risks: Half the panel remains cautious. Scotiabank's Nicholas Yulico sits at Sector Perform with a $158 target, and RBC Capital's Brad Heffern carries Sector Perform at $157. New-supply headwinds in Sun Belt markets, promotional discounting in weaker submarkets, and interest-rate sensitivity all remain sector-level risks.
Sociedad Química y Minera (SQM) – Citi Turns Bullish on Lithium Recovery
Chilean lithium and specialty chemicals producer SQM was upgraded from Neutral to Buy on Thursday by Citigroup. Citi's thesis focuses on lithium prices stabilizing off cycle lows, tighter industry discipline from major producers, and SQM's low-cost Salar de Atacama assets positioning the company for outsized operating leverage as the market rebalances.
Shares traded near $80.09 during Thursday's session, up about 2.32%, giving SQM a market capitalization near $22.9 billion. The 52-week range of $40.58 to $98.00 shows the stock has doubled off the lows on early signs of lithium market recovery. The trailing price-to-earnings multiple sits at 16.6.
Consensus reads buy on seven ratings, with three bullish, three neutral, and one bearish. The average price target of $80.14 implies flat return from Thursday's level, but Scotiabank's Ben Isaacson raised his target to $104 on August 24 and JP Morgan's Lucas Ferreira carries Overweight at $100.
Risks: The panel is not unanimous. BofA Securities' Isabella Simonato maintained Underperform in March with a $53 target, and Goldman Sachs' Marcio Farid holds Neutral at $82. Lithium spot price volatility, regulatory dynamics with the Chilean state over lithium concessions, and Chinese battery-grade lithium supply remain the primary swing factors.
Found this helpful? Share it with others.